Combating Dopaminergic Neurodegeneration in Parkinson’s Disease through Nanovesicle Technology
ACS Chemical Neuroscience · 2023
DOI: 10.1021/acschemneuro.3c00070 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ACS Chemical Neuroscience, 2023. Verfasst von Rubina Roy und 3 weiteren Autor:innen. Beteiligte Einrichtung: Cellular and Molecular Neurobiology Laboratory, Department of Life Science and Bioinformatics, Assam University, Silchar 788011, Assam, India. Hauptthemen laut MEDLINE: Parkinson Disease. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 208 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cellular and Molecular Neurobiology Laboratory, Department of Life Science and Bioinformatics, Assam University, Silchar 788011, Assam, India.
- Department of Zoology, Pandit Deendayal Upadhyaya Adarsha Mahavidyalaya (PDUAM), Eraligool, Karimganj 788723, Assam, India.
- Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), Ahmedabad 382355, Gandhinagar, Gujarat, India.
ORCID-Profile: Rajib Paul, Pallab Bhattacharya, Anupom Borah
Zitieren
APA
Roy, R., Paul, R., Bhattacharya, P., & Borah, A. (2023). Combating Dopaminergic Neurodegeneration in Parkinson’s Disease through Nanovesicle Technology. ACS Chemical Neuroscience. https://doi.org/10.1021/acschemneuro.3c00070
Vancouver
Roy R, Paul R, Bhattacharya P, Borah A. Combating Dopaminergic Neurodegeneration in Parkinson’s Disease through Nanovesicle Technology. ACS Chemical Neuroscience. 2023. doi:10.1021/acschemneuro.3c00070
BibTeX
@article{Roy2023,
author = {Roy, Rubina and Paul, Rajib and Bhattacharya, Pallab and Borah, Anupom},
title = {Combating Dopaminergic Neurodegeneration in Parkinson’s Disease through Nanovesicle Technology},
journal = {ACS Chemical Neuroscience},
year = {2023},
doi = {10.1021/acschemneuro.3c00070}
}
EUVIMED